Abstract:Asthma is a worldwide chronic airways disease that affects more than 300 million children and adults worldwide ( 1 ). Affected individuals suffer from wheezing, chest tightness, shortness of breath, and cough that is attributed to airway narrowing, excessive mucus production, and persistent inflammation. Symptoms often begin in early childhood and are believed to be initiated by a severe inflammatory response in a developmentally immature immune system. Initiating factors include infection with rhinovirus or other respiratory viral infections, exposure to particulate matter such as tobacco smoke or air pollution, and even supplemental oxygen used to treat preterm infants. Asthma exacerbations typically occur after exercise, T-helper cell type 2 (Th2)-mediated allergic responses, respiratory infections, and exposure to various pulmonary irritants. Although it is a minor inconvenience for most individuals, asthma can be a major, life-threatening health concern for others. The key to understanding this variability lies in defining the complex gene–environment interactions that drive asthma and other airway diseases such as chronic obstructive pulmonary disease (COPD). In this issue of the Journal , Zhu and colleagues (pp. 695–704 ), report on what may be a key observation in furthering our understanding of why the airway epithelium of individuals with asthma or COPD have less secretoglobin family 1A member 1 (SCGB1A1; also known as club cell secretory protein [CCSP], CC10, and CC16) compared with healthy control subjects ( 2 ). In their studies, they discovered that viral infections and Th2 cytokines inhibit expression of SCGB1A1 by inhibiting expression of the transcription factor forkhead box A2 (FOXA2), which is known to regulate Th2-mediated inflammation and goblet cell hyperplasia. So why is this important? SCGB1A1 is a small homodimeric molecule that is secreted by nonciliated airway club cells and mucus-producing cells of the uterus. It is the most abundant protein found in airway lining fluid, and can be detected in serum and urine. Although its exact physiologic function has yet to be defined, SCGB1A1 possesses antiinflammatory and antitoxicant properties via its ability to inhibit phospholipase A2 activity, sequester hydrophobic ligands such as polychlorinated biphenyls and steroids, alter chemotaxis, and affect cytokine production ( 3 ). These properties indicate that SCGB1A1 is an important defense molecule of the lung. Hence, it is not surprising that lower levels of SCGB1A1 have been detected in BAL fluid, serum, and urine of individuals with asthma or and COPD compared with healthy control subjects ( 4 ). Similarly, airspace enlargement is greater in Scgb1a1-null mice exposed to cigarette smoke than wild-type controls. Additionally, several inflammatory and autoimmune diseases have been associated with a SNP in the Scgb1a1 gene, resulting in reduced levels of SCGB1A1 protein ( 5 ). Improving the respiratory health of individuals with asthma or COPD therefore requires a better understanding of how SCGB1A1 is suppressed. To identify factors capable of suppressing SCGB1A1 in airways disease, Zhu and colleagues analyzed three previously published transcriptomic datasets of human brushed bronchial epithelial cells isolated from subjects with asthma and control subjects without asthma. They confirmed that individuals with asthma express less Scgb1a1 mRNA than those without asthma, and found that this correlated with reduced mRNA encoding FOXA2, a known transcriptional inducer of Scgb1a1 mRNA. The authors went on to show that 1 ) Scgb1a1 and FoxA2 were both suppressed in an ovalbumin mouse model of airway hyperreactivity, 2 ) the Th2 cytokines IL-4 and IL-13 suppressed epithelial expression of both FOXA2 and SCGB1A1, 3 ) rhinovirus infection inhibited epithelial expression of these two proteins, and 4 ) overexpression of FOXA2 stimulated Scgb1a1 transcription and abundance of SCGB1A1 protein. Perhaps most compelling is the observation that overexpression of FOXA2 restored expression of SCGB1A1 in epithelial cells treated with IL-13 or infected with rhinovirus. Collectively, these findings provide strong experimental evidence that two known mediators of airways disease, namely, rhinovirus and Th2 cytokines, can suppress epithelial expression of SCGB1A1 via inhibition of FOXA2 ( Figure 1 ). Such knowledge may prove to be a critical key needed to restore expression of SCGB1A1 in the airways of individuals with asthma or COPD. Figure 1. Cartoon model summarizing the key findings of Zhu and colleagues ( 2 ). The production of T-helper cell type 2 cytokines such as IL-4 and IL-13 or infection with -Abstract Truncated-

Gasdermin B, an asthma-susceptibility gene, promotes MAVS-TBK1 signaling and airway inflammation

The Asthma Risk Gene, GSDMB, Promotes Mitochondrial DNA-induced ISGs Expression

Genetic and Pharmacological Targeting of GSDMD Ameliorates Systemic Inflammation in Macrophage Activation Syndrome

Autoimmune Disease Variants Regulate GSDMB Gene Expression in Human Immune Cells and Whole Blood

Gasdermin D silencing alleviates airway inflammation and remodeling in an ovalbumin-induced asthmatic mouse model

From gene identifications to therapeutic targets for asthma: Focus on great potentials of TSLP, ORMDL3, and GSDMB

Lipid Metabolism-Related Genes Are Involved in the Occurrence of Asthma and Regulate the Immune Microenvironment

Airway Epithelial Cgas is Critical for Induction of Experimental Allergic Airway Inflammation.

Association of GAB1 gene with asthma susceptibility and the efficacy of inhaled corticosteroids in children

Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets

Genome-wide Association Analysis in Asthma Subjects Identifies SPATS2L As a Novel Bronchodilator Response Gene.

Genetic susceptibility to acute viral bronchiolitis

Uncovering Potential Key Genes Associated with the Pathogenesis of Asthma: A Microarray Analysis of Asthma-Relevant Tissues

Airway epithelial-derived exosomes induce acute asthma exacerbation after respiratory syncytial virus infection

Modulation of Vagal Sensory Neurons via High Mobility Group Box-1 and Receptor for Advanced Glycation End Products: Implications for Respiratory Viral Infections

PGAP3 regulates human bronchial epithelial cell mRNAs present in asthma and respiratory virus reference data sets

Role of GSDM family members in airway epithelial cells of lung diseases: a systematic and comprehensive transcriptomic analysis

An Elusive Fox that Suppresses Scgb1a1 in Asthma Has Been Found

Identification of common genes of rhinovirus single/double‐stranded RNA‐induced asthma deterioration by bioinformatics analysis

Respiratory syncytial virus-induced high mobility group box 1 secretion modulates innate immune response to promote inflammation

ITGB4 deficiency induces mucus hypersecretion by upregulating MUC5AC in RSV-infected airway epithelial cells